Clinical Trials Logo

Artificial Intelligence clinical trials

View clinical trials related to Artificial Intelligence.

Filter by:
  • Enrolling by invitation  
  • Page 1

NCT ID: NCT05984082 Enrolling by invitation - Clinical trials for Artificial Intelligence

Checklist for AI in Medical Imaging (CLAIM) Consensus Panel

CLAIM
Start date: August 1, 2023
Phase:
Study type: Observational

The investigators will revise the Checklist for AI in Medical Imaging (CLAIM) guideline using Delphi consensus methods. An international panel of physicians, researchers, and journal editors with expertise in AI in medical imaging -- including radiology, pathology, dermatology, GI endoscopy, and ophthalmology -- will complete up to 3 web-based surveys. Participants who complete all survey rounds will be credited as contributors on resulting publications.

NCT ID: NCT05860777 Enrolling by invitation - Clinical trials for Artificial Intelligence

Harnessing Health IT to Promote Equitable Care for Patients With Limited English Proficiency and Complex Care Needs

Start date: May 1, 2023
Phase: N/A
Study type: Interventional

This is a pragmatic trial that will measure if the use of AI to identify patients with complex care needs and language barriers, as well as active reaching out to clinicians to offer the use of interpreter services will improve the frequency of interpreter use and reduce the time to first interpreter use

NCT ID: NCT05293457 Enrolling by invitation - Clinical trials for Artificial Intelligence

AI-assisted Gastroscopic Varicose Vein Diagnosis

Start date: April 25, 2022
Phase:
Study type: Observational

Validation of the accuracy of AI in assisting gastroscopic varices diagnosis through a prospective multicenter study

NCT ID: NCT04968418 Enrolling by invitation - Clinical trials for Artificial Intelligence

Deep Neural Network for Stroke Patient Gait Analysis and Classification

Start date: July 20, 2021
Phase:
Study type: Observational

Lower limbs of stroke patients gradually recover through Brunnstrom stages, from initial flaccid status to gradually increased spasticity, and eventually decreased spasticitiy. Throughout this process. after stroke patients can start walking, their gait will show abnormal gait patterns from healthy subjects, including circumduction gait, drop foot, hip hiking and genu recurvatum. For these abnormal gait patterns, rehabilitation methods include ankle-knee orthosis(AFO) or increasing knee/pelvic joint mobility for assistance. Prior to this study, similar research has been done to differentiate stroke gait patterns from normal gait patterns, with an accuracy of over 96%. This study recruits subject who has encountered first ever cerebrovascular incident and can currently walk independently on flat surface without assistance, and investigators record gait information via inertial measurement units strapped to their bilateral ankle, wrist and pelvis to detect acceleration and angular velocity as well as other gait parameters. The IMU used in this study consists of a 3-axis accelerometer, 3-axis gyroscope and 3-axis magnetometer, with a highest sampling rate of 128Hz. Afterwards, investigators use these gait information collected as training data and testing data for a deep neural network (DNN) model and compare clinical observation results by physicians simultaneously, in order to determine whether the DNN model is able to differentiate the types of abnormal gait patterns mentioned above. If this model is applied in the community, investigators hope it is available to early detect abnormal gait patterns and perform early intervention to decrease possibility of fallen injuries. This is a non-invasive observational study and doesn't involve medicine use. Participants are only required to perform walking for 6 minutes without assistance on a flat surface. This risk is extremely low and the only possible risk of this study is falling down during walking.

NCT ID: NCT04719117 Enrolling by invitation - Clinical trials for Artificial Intelligence

Retrograde Cholangiopancreatography AI Assisted System Validation on Effectiveness and Safety

Start date: September 1, 2020
Phase:
Study type: Observational

In this study, the investigators proposed a prospective study about the effectiveness of artificial intelligence system for Retrograde cholangiopancreatography. The subjects would be include in an analyses groups. The AI-assisted system helps endoscopic physicians estimate the difficulty of Endoscopic retrograde cholangiopancreatography for choledocholithiasis and make recommendations based on guidelines and difficulty scores. The investigators used the stone removal times, success rate of stone extraction and Operating time to reflect the difficulty of the operation, and evaluated whether the results of the AI system were correct.